Synergistic interaction of 2,3,7,8,‐tetrachlorodibenzo‐p‐dioxin and hydrocortisone in the induction of cleft palate in mice
- 1 February 1986
- journal article
- research article
- Published by Wiley in Teratology
- Vol. 33 (1), 29-35
- https://doi.org/10.1002/tera.1420330106
Abstract
Glucocorticoids cause cleft palate in sensitive mouse strains by interfering with the proliferation of mesenchymal cells in the palatal shelves; 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) also causes cleft palate, but its effects involve the epithelial cells. The purpose of this study was to examine the interaction of TCDD and the glucocorticoid hydrocortisone in the induction of malformations. Pregnant C57BL/6N mice were treated on gestation days 10–13 with TCDD (0 or 3 μg/kg, p.o.), hydrocortisone (0, 25, 50, or 100 mg/kg, s.c.) or a combination of TCDD and hydrocortisone. The dams were killed on gestation day 18 and the mice were analyzed for maternal and fetal toxicity and soft tissue malformations. TCDD alone had no effect on litter size, fetal weight or viability, or maternal weight gain. This dose of TCDD is essentially a threshold dose and it did not produce cleft palate in this study, but all the TCDD-treated fetuses had hydronephrosis, the most sensitive indicator of TCDD teratogenicity. Hydrocortisone alone caused dose-related decreases in fetal weight and maternal liver/body weight ratios, and dose-related increases in cleft palate (0, 5, 10, and 30%). No effects of hydrocortisone were detected on litter size or fetal viability, but maternal weights were affected. Combination of all doses of hydrocortisone with TCDD resulted in a 100% incidence of cleft palate, accompanied by a decrease in litter size and fetal weight and an increase in fetal mortality related to the dose of hydrocortisone. TCDD tended to reverse the decrease in liver/body weight ratio seen with hydrocortisone alone. Morphological assessment of the palatal shelves late on gestation day 14 revealed that the embryos exposed to both TCDD and hydrocortisone resembled hydrocortisone alone. The synergism observed between these two teratogens may be due to changes in the receptors which mediate sensitivity to the induction of cleft palate.This publication has 33 references indexed in Scilit:
- Immunocytochemical localization of glucocorticoid receptors in midgestation murine embryos and human embryonic cultured cells.Journal of Histochemistry & Cytochemistry, 1984
- Effect of thyroidectomy and thyroxine on 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induced toxicityToxicology and Applied Pharmacology, 1984
- 2,3,7,8‐Tetrachlorodibenzo‐p‐dioxin‐ induced cleft palate in the mouse: Evidence for alterations in palatal shelf fusionTeratogenesis, Carcinogenesis, and Mutagenesis, 1984
- Interactions Affecting Drug AbsorptionClinical Pharmacokinetics, 1984
- Mechanisms of chemically-induced cleft palateTrends in Pharmacological Sciences, 1983
- Cortisone-induced cleft palate in A/J mice: Failure of palatal shelf contactTeratology, 1981
- Interaction between Glucocorticoids and Epidermal Growth Factor In Vitro in the Growth of Palatal Mesenchymal Cells from the Human EmbryoDifferentiation, 1981
- Association between the presence of the Ah receptor in embryonic murine tissues and sensitivity to TCDD‐induced cleft palateTeratogenesis, Carcinogenesis, and Mutagenesis, 1981
- Inhibitory effect of corticoids on the proliferative pattern in mouse palatal processesTeratology, 1975
- INDUCTION OF ARYL HYDROCARBON (BENZO[a]PYRENE) HYDROXYLASE AND TYROSINE AMINOTRANSFERASE IN HEPATOMA CELLS IN CULTUREThe Journal of cell biology, 1974